Other
18F-DCFPyL PET/CT
18F-DCFPyL PET/CT is an intervention with 5 clinical trials. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
2
40%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed1
Enrolling by invitation1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
unknown240%
completed120%
enrolling_by_invitation120%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
enrolling_by_invitationphase_2
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
NCT03459820
terminatedphase_1
Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy
NCT03619655
unknown
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104
completedphase_2
Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer
NCT03001895
unknown
PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life
NCT03609736
Clinical Trials (5)
Showing 5 of 5 trials
NCT03459820Phase 2
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
NCT03619655Phase 1
Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy
NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT03001895Phase 2
Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer
NCT03609736
PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life
All 5 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 5